EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
102 hedge funds and large institutions have $182M invested in Eiger BioPharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
46% less call options, than puts
Call options by funds: $1.09M | Put options by funds: $2.03M
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
102
Holding in Top 10
2
Calls
$1.09M
Puts
$2.03M
Top Buyers
| 1 | +$11.3M | |
| 2 | +$3.98M | |
| 3 | +$3.79M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.77M |
| 5 |
BlackRock
New York
|
+$2.27M |
Top Sellers
| 1 | -$2.81M | |
| 2 | -$2.04M | |
| 3 | -$2.04M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.2M |
| 5 |
D.E. Shaw & Co
New York
|
-$989K |